Psoriasis Vulgaris
📧 Sign up to get email alerts when something new happens for Psoriasis Vulgaris.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: Laser Induced Changes to Innervation and Vascularisation of Psoriatic Skin [NA]
Completed clinical trial investigating laser-induced changes to innervation and vascularization in psoriatic skin.
-
CLINICAL_TRIALS trial_result · 2024-10-26Clinical Trial Update: Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamic Effect of Different Concentrations of a New Anti-inflammatory Substance in Subjects With Chronic Plaque Psoriasis [Phase 1]
This document reports the completion of a Phase 1 clinical trial evaluating safety, tolerability, and pharmacodynamic effects of a new anti-…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Safety and Efficacy of CD10367 in Psoriasis Vulgaris [Phase 2]
Phase 2 study evaluating the safety and efficacy of CD10367 in adults with psoriasis vulgaris; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Therapeutic Drug Monitoring of Guselkumab in Psoriasis Patients [Phase 4]
Phase 4 trial evaluating therapeutic drug monitoring of guselkumab in psoriasis patients has completed.
-
CLINICAL_TRIALS research · 2024-07-19Clinical Trial Update: Topical Thymoquinone in Psoriasis Vulgaris [NA]
A clinical trial evaluating topical thymoquinone for Psoriasis vulgaris is listed as not yet recruiting, sponsored by Assiut University.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-07-09Clinical Trial Update: Biofeedback for Psoriasis [NA]
A completed clinical trial evaluating biofeedback for psoriasis has finished its study.
-
CLINICAL_TRIALS trial_result · 2024-07-01Clinical Trial Update: Effect of Semaglutide on the Psoriatic Lesions in Patients With Type 2 Diabetes Mellitus [Phase 4]
A Phase 4 trial evaluating the effect of semaglutide on psoriatic lesions in adults with type 2 diabetes has completed.
-
CLINICAL_TRIALS research · 2024-06-12Clinical Trial Update: Botox Versus Tacrolimus in Psoriasis Vulgaris [Phase 4]
A Phase 4 clinical trial comparing Botox (onabotulinumtoxinA) with tacrolimus for psoriasis vulgaris is listed as not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-06-03Clinical Trial Update: Association Between Apical Periodontitis and Psoriasis Vulgaris
A completed clinical trial from the University of Siena studied the association between apical periodontitis and psoriasis vulgaris. The stu…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: PSODEEP2 Pilot Study on Koebner Induction in Psoriasis [NA]
PSODEEP2 is a pilot study at Skane University Hospital to study Koebner induction in psoriasis vulgaris, and it is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-04-30Clinical Trial Update: Predicting Inflammatory Skin Disease Response to IL-23 Blockade [Phase 4]
A Phase 4 clinical trial from UC San Francisco evaluated whether biomarkers can predict response to IL-23 blockade in psoriasis vulgaris, wi…
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Shuiniujiao Dihuang Decoction With Variation for the Treatment of Psoriasis [Phase 2]
Phase 2 clinical trial exploring Shuiniujiao Dihuang Decoction with variation for treating psoriasis vulgaris has an unknown status.
-
CLINICAL_TRIALS trial_result · 2024-02-05Clinical Trial Update: Therapeutic Drug Monitoring of Risankizumab in Psoriasis Patients (BIOLOPTIM-RIS) [Phase 4]
Phase 4 clinical trial update evaluating therapeutic drug monitoring of risankizumab in psoriasis patients.
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: Improvement of Psoriasis Patients' Adherence to Topical Drugs [NA]
A completed clinical trial examining adherence improvements to topical therapies in psoriasis vulgaris.
-
CLINICAL_TRIALS trial_result · 2024-01-18Clinical Trial Update: Therapeutic Drug Monitoring of Tildrakizumab in Psoriasis Patients [Phase 4]
Phase 4 clinical trial update evaluating therapeutic drug monitoring of tildrakizumab in psoriasis patients.
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: Anti-Inflammatory Effects of 0.045% Tazarotene/0.01% Halobetasol Lotion in Psoriasis [Phase 4]
Phase 4 trial update on anti-inflammatory effects of a tazarotene/halobetasol lotion in psoriasis vulgaris.
-
CLINICAL_TRIALS trial_result · 2023-08-29Clinical Trial Update: Psoriatic Immune Response to Tildrakizumab [Phase 4]
Phase 4 clinical trial update evaluating the psoriatic immune response to tildrakizumab in psoriasis vulgaris.
-
CLINICAL_TRIALS trial_result · 2023-08-25Clinical Trial Update: A Phase 3 Clinical Study of KHK 4827 [Phase 3]
Phase 3 trial update for KHK 4827 across psoriasis-related conditions; study completed.
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: Using Acetylcysteine and Vitamin E With Psoriasis Vulgaris [Phase 3]
Phase 3 clinical trial evaluating acetylcysteine and vitamin E for psoriasis vulgaris is in progress with unknown status.
-
CLINICAL_TRIALS trial_result · 2023-03-17Clinical Trial Update: Blue Light Phototherapy [NA]
Clinical trial update for blue light phototherapy (completed) with results posted; conditions studied include Grover's Disease and Psoriasis…
-
CLINICAL_TRIALS withdrawal · 2023-03-15Clinical Trial Update: Effect of Bimekizumab in Patients With Psoriasis Vulgaris and Active Psoriatic Arthritis [Phase 4]
A Phase 4 trial evaluating bimekizumab in psoriasis vulgaris with active psoriatic arthritis was withdrawn.
-
CLINICAL_TRIALS trial_result · 2023-03-02Clinical Trial Update: A Phase 3 Study of Efficacy and Safety of AK101 in Subjects With Psoriasis [Phase 3]
Phase 3 trial update evaluating efficacy and safety of AK101 in psoriasis vulgaris has completed.
-
CLINICAL_TRIALS trial_result · 2022-08-05Clinical Trial Update: Efficacy and Safety of Novel Formulations of Topical Calcipotriol in Patients With Mild to Moderate Plaque Psoriasis [Phase 1, Phase 2]
Phase 1/2 trial evaluating efficacy and safety of novel topical calcipotriol formulations in mild to moderate psoriasis (psoriasis vulgaris)…
-
CLINICAL_TRIALS trial_result · 2022-02-24Clinical Trial Update: Clinical Trial of Probiotic Supplementation in Psoriasis Vulgaris [Phase 1, Phase 2]
Clinical trial update for probiotic supplementation in psoriasis vulgaris undergoing Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2021-11-01Clinical Trial Update: Phase 2, Open-label, Study of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-line Therapy [Phase 2]
Phase 2 open-label study of KD025 in psoriasis vulgaris patients who failed first-line therapy has completed; results posted.